Serum Institute of India to invest $68 mln in UK's Oxford Biomedica

Vaccine producer Serum Institute of India will invest 50 million pounds ($68.24 million) in Oxford Biomedica, one of the COVID-19 vaccine manufacturers for drug major AstraZeneca, the British cell therapy firm said on Wednesday.

($1 = 0.7327 pounds)